Contact Us
Drug Search Results
More Filters [+]

Barusiban

Alternative Names: barusiban, fe-200440, fe200440, fe 200440
Latest Update: 2021-12-01
Latest Update Note: PubMed Publication

Product Description

Barusiban is an oxytocin antagonist under development for potential use as tocolytic in preterm-labor patients. Barusiban (FE 200440) is a peptide oxytocin antagonist for potential future use as a tocolytic drug in preterm-labor patients, being slightly smaller than atosiban. (Sourced from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313255/)

Mechanisms of Action: OXTR Antagonist

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Ferring
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Barusiban

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Infertility|Other|Obstetric Labor, Premature|Pregnancy Outcomes|Infertility, Male|Infertility, Female

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
BASIC

P2

Completed

Infertility, Male|Infertility, Female

2014-10-08

BASIC

P2

Completed

Infertility

2014-10-01

EFFORT

P2

Completed

Pregnancy Outcomes

2010-12-02

EFFORT

P2

Completed

Other

2010-05-01

Recent News Events

Date

Type

Title

12/01/2021

PubMed

 Is oxytocin receptor antagonist administration around embryo transfer associated with IVF treatment success? A systematic review and meta-analysis.

09/01/2021

PubMed

 Oxytocin antagonists for assisted reproduction.

10/15/2020

News Article

 Ferring Pharmaceuticals to Share New Reproductive Medicine Data at ASRM 2020 Scientific Congress & Expo

06/23/2020

PubMed

 Barusiban, a selective oxytocin receptor antagonist: placental transfer in rabbit, monkey, and human.

10/14/2019

News Article

 Ferring Pharmaceuticals to Present New Fertility Data at ASRM 2019 Scientific Congress & Expo

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions